Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Mercury Pharmaceuticals Ltd, Capital House, 85 King William Street, London EC4N 7BL, UK
Midazolam 5mg/ml Solution for Injection/Infusion.
| Pharmaceutical Form |
|---|
|
Solution for Injection / Infusion. |
Each 1ml solution contains 5mg midazolam presented in 2ml and 10ml ampoules.
Excipient(s) with known effect: Each 1ml contains 1.97 mg of Sodium.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Midazolam |
Midazolam is a derivative of the imidazobenzodiazepine group. The free base is a lipophilic substance with low solubility in water. The basic nitrogen in position 2 of the imidazobenzodiazepine ring system enables the active ingredient of midazolam to form water-soluble salts with acids. |
| List of Excipients |
|---|
|
Sodium chloride |
Clear One Point Cut (OPC) 2ml & 10ml glass ampoules, glass type I, Ph. Eur.
Pack sizes: 5 × 2ml ampoules; 10 × 2ml ampoules. 5 × 10ml ampoules; 10 × 10ml ampoules
Not all pack sizes may be marketed.
Mercury Pharmaceuticals Ltd, Capital House, 85 King William Street, London EC4N 7BL, UK
PL 12762/0591
20/12/2005
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
